Tremfya on SilverScript Choice (S5601-002)
guselkumab
Covered, with prior authorization required.
Tier 5 (specialty tier). Quantity limit of 1 per 28 days.
$3,762.51
Patient pays / month, after deductible
$4,223.76
Patient pays / month, before the $615.00 deductible
Not offered
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap
TREMFYA 100 mg/mL Injection at a preferred retail pharmacy, from the plan's negotiated price of $15,050.04 for a month. Other covered strengths are listed below.
Prior authRequired on all 5 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 5 covered strengths and forms
| Form | Tier | Patient pays / month | Limits |
|---|---|---|---|
| TREMFYA 100 mg/mL Injection | 5 | $3,762.51 | PA · 1 per 28 days |
| TREMFYA 100 mg/mL Injection | 5 | $3,763.24 | PA · 1 per 28 days |
| TREMFYA 200 mg/2mL Injection | 5 | $7,977.50 | PA · 4 per 28 days |
| TREMFYA 200 mg/2mL Injection | 5 | $7,977.50 | PA · 4 per 28 days |
| TREMFYA 200 mg/2mL Injection | 5 | $7,977.50 | PA · 4 per 28 days |
Other IL-17 and IL-23 biologics on this plan
Verify with the plan before prescribing or filling. Member services: (866)235-5660. Data from the CMS 2026 Part D formulary and pricing files. Full plan details
Plan ID s5601-002